Notice of updates
We’ve updated our Financial Services Guide (FSG), effective 18 November 2025. By continuing to use our services after this date, you accept the revised terms.
Read FSG
Notice of updates
We’ve updated our Financial Services Guide (FSG), effective 18 November 2025. By continuing to use our services after this date, you accept the revised terms.
Read FSG
0.09 (6.04%)Mean Reversion
Neutral
Trend
Neutral
Event
Neutral
Mqv
Very Weak
Garp
Very Weak
Mqv Small
Neutral
Value
Consensus
Price
Strong
Earnings
Neutral
Earnings
Very Weak
Dividends
Very Weak
Capital Efficiency
Very Weak
Balance Sheet
Strong
Website
Vitrafy Life Sciences Ltd.
Telephone
61.3.4331.9974
Address
Suite 2, Level 11, 385 Bourke Street, Melbourne, Victoria (VIC) 3000
Market Cap
PE
EV/EBITDA
DIV Yield
Franking
Ex Dividend Date (est.)
52 weeks range
Low 1.08 - 2.1
Trade Value (12mth)
AU$13,947.00
1 week
2.76%
1 month
10.37%
YTD
-14.86%
1 year
0%
All time high
2.10
EPS 3 yr Growth
N/A
EBITDA Margin
N/A
Operating Cashflow
N/A
Free Cash Flow Return
N/A
ROIC
N/A
Interest Coverage
0.00
Quick Ratio
N/A
Shares Outstanding (Fully Diluted)
N/A
HALO Sector
Healthcare
Next Company Report Date
11-Aug-26
Next Ex Dividend Date
N/A
Next Dividend Pay Date
N/A
Reporting Currency
AUD
Short Sell (% of issue)
0.00
| Date | Announcements |
| 23 October 25 | |
| 22 October 25 | |
| 20 October 25 | |
| 17 October 25 | |
| 16 October 25 |
Historical data
Forecast data
| 2020 | 2021 | 2022 | 2023 | 2025 | 2026 | 2027 |
Ex Dividend Date (est.)
DIV Yield
Franking Level
DPSg
Quality Yield
Falling Divs over next 2
Consensus Score
Recommendation
EPS 1 month Change
Quality Yield
Falling Divs over next 2
Percent of Issue
Value ($M)
Prior Change
7 Day Change
1 Month Change
3 Months Change
Access data on short interest, stock performance, and potential short-selling candidates across various markets to make informed decisions and optimize your trading strategies.
